Intravenous Ketamine Infusion as an Adjunctive Pain Treatment for Erythromelalgia: A Pediatric Case Report

A A Pract. 2022 Apr 13;16(4):e01582. doi: 10.1213/XAA.0000000000001582.

Abstract

Erythromelalgia is a rare neurovascular pain condition characterized by erythematous, warm, and painful extremities. Symptoms are exacerbated by heat and relieved by cooling. Treatment is challenging and focuses on symptom control with various medications and therapies targeted toward eliminating destructive cooling behaviors. This pediatric case was notable because the patient's pain dramatically improved after a short-term, low-dose ketamine infusion, allowing her to finally wean off detrimental cooling practices of her extremities. Intravenous ketamine has rarely been described as an adjunctive analgesic strategy for erythromelalgia.

Publication types

  • Case Reports

MeSH terms

  • Analgesics / therapeutic use
  • Child
  • Erythromelalgia* / complications
  • Erythromelalgia* / diagnosis
  • Erythromelalgia* / drug therapy
  • Female
  • Humans
  • Ketamine* / therapeutic use
  • Pain / drug therapy
  • Pain / etiology
  • Pain Management

Substances

  • Analgesics
  • Ketamine